Universal Display Corporation - OLED

OLED Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
OLED	1.4	-0.8	-4.2	-27.2	-33.6	-14.3	-1.4	-29.9	464.4	94.4
S&P 500	1.0	1.8	-0.9	2.7	7.3	26.5	31.0	80.1	196.5	33856.2

Compare OLED with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	OLED
name	Universal Display Corporation
price	149.24
changes percentage	1.44
change	2.12
day low	146.32
day high	151.29
year high	237
year low	143.25
market cap	7083139336
price avg 50	160.08
price avg 200	183.84
exchange	NASDAQ
volume	1031909
avg volume	589944
open	148.89
previous close	147.12
eps	4.97
pe	30.03
earnings announcement	2025-02-20T10:59:00.000+0000
shares outstanding	47461400
timestamp	2025-01-17 21:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 46.0%

Overall Quarterly Financial Health: 80.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001005284
revenue	576429000	616619000	-6.52
gross profit	441053000	488723000	-9.75
gross profit ratio	0.77	0.79	-3.46
research and development expenses	130481000	117062000	11.46
operating expenses	223864000	221613000	1.02
interest income	28166000	7811000	260.59
interest expense	0	7811000	-100.00
ebitda	260591000	309384000	-15.77
ebitdaratio	0.45	0.5	-9.90
operating income	217189000	267110000	-18.69
operating income ratio	0.38	0.43	-13.02
net income	203011000	210061000	-3.36
net income ratio	0.35	0.34	3.38
eps	4.25	4.41	-3.63

Overall Score of Annual Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 576 million in 2023 from 617 million in 2022 representing a change of -6.52%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 441 million in 2023 from 489 million in 2022 representing a change of -9.75%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 224 million in 2023 from 222 million in 2022 representing a change of 1.02%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 261 million in 2023 from 309 million in 2022 representing a change of -15.77%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 217 million in 2023 from 267 million in 2022 representing a change of -18.69%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 203 million in 2023 from 210 million in 2022 representing a change of -3.36%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 4.25 in 2023 from 4.25 in 2022 representing a change of -3.63%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 130 million in 2023 from 117 million in 2022 representing a change of 11.46%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001005284
revenue	161627000	158505000	1.97
gross profit	121110000	115505000	4.85
gross profit ratio	0.75	0.73	2.83
research and development expenses	36089000	36826000	-2.00
operating expenses	54105000	59068000	-8.40
interest income	10592000	9913000	6.85
interest expense	0	0	NaN
ebitda	77952000	56437000	38.12
ebitdaratio	0.48	0.43	13.28
operating income	67005000	56437000	18.73
operating income ratio	0.41	0.36	16.43
net income	66870000	52337000	27.77
net income ratio	0.41	0.33	25.30
eps	1.4	1.1	27.27

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 162 million in 2024Q3 from 159 million in 2024Q2 representing a change of 1.97%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 121 million in 2024Q3 from 116 million in 2024Q2 representing a change of 4.85%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 54 million in 2024Q3 from 59 million in 2024Q2 representing a change of -8.4%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 78 million in 2024Q3 from 56 million in 2024Q2 representing a change of 38.12%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 67 million in 2024Q3 from 56 million in 2024Q2 representing a change of 18.73%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 67 million in 2024Q3 from 52 million in 2024Q2 representing a change of 27.77%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.4 in 2024Q3 from 1.4 in 2024Q2 representing a change of 27.27%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 36 million in 2024Q3 from 37 million in 2024Q2 representing a change of -2.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001005284
total assets	1668961000	1532820000	8.88
total liabilities	221735000	257451000	-13.87
total equity	1447226000	1275369000	13.48
cash and cash equivalents	91985000	93430000	-1.55
short term investments	422137000	484345000	-12.84
long term investments	299548000	259861000	15.27
total current assets	917132000	899450000	1.97
total non current assets	751829000	633370000	18.70
total current liabilities	118822000	135697000	-12.44
total non current liabilities	102913000	121754000	-15.47
common stock	487000	491000	-0.81
retained earnings	789553000	653277000	20.86
total debt	22855000	29039000	-21.30

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,669 million in 2023 from 1,533 million in 2022 representing a change of 8.88%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 222 million in 2023 from 257 million in 2022 representing a change of -13.87%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 1,447 million in 2023 from 1,275 million in 2022 representing a change of 13.48%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 917 million in 2023 from 899 million in 2022 representing a change of 1.97%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 119 million in 2023 from 136 million in 2022 representing a change of -12.44%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 790 million in 2023 from 653 million in 2022 representing a change of 20.86%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 23 million in 2023 from 29 million in 2022 representing a change of -21.3%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 92 million in 2023 from 93 million in 2022 representing a change of -1.55%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 422 million in 2023 from 484 million in 2022 representing a change of -12.84%. This indicates a decrease in short-term investment holdings.

  Common Stock: Common Stock decreased to 0 in 2023 from 0 in 2022 representing a change of -0.81%. This indicates a decrease in ownership interest.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001005284
total assets	1810882000	1776561000	1.93
total liabilities	224132000	249723000	-10.25
total equity	1586750000	1526838000	3.92
cash and cash equivalents	79559000	92856000	-14.32
short term investments	471993000	437667000	7.84
long term investments	396931000	428640000	-7.40
total current assets	941846000	959481000	-1.84
total non current assets	869036000	817079999	6.36
total current liabilities	131165000	151999000	-13.71
total non current liabilities	92967000	97724000	-4.87
common stock	488000	488000	0.00
retained earnings	907776000	860058000	5.55
total debt	20112000	24655000	-18.43

Overall Score of Quarterly Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,811 million in 2024Q3 from 1,777 million in 2024Q2 representing a change of 1.93%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 224 million in 2024Q3 from 250 million in 2024Q2 representing a change of -10.25%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 1,587 million in 2024Q3 from 1,527 million in 2024Q2 representing a change of 3.92%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 472 million in 2024Q3 from 438 million in 2024Q2 representing a change of 7.84%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 131 million in 2024Q3 from 152 million in 2024Q2 representing a change of -13.71%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 908 million in 2024Q3 from 860 million in 2024Q2 representing a change of 5.55%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 20 million in 2024Q3 from 25 million in 2024Q2 representing a change of -18.43%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 80 million in 2024Q3 from 93 million in 2024Q2 representing a change of -14.32%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 942 million in 2024Q3 from 959 million in 2024Q2 representing a change of -1.84%. This indicates a worsen liquidity position.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001005284
net change in cash	-1445000	-218563000	99.34
operating cash flow	154777000	126815000	22.05
free cash flow	28422000	79609000	-64.30
capital expenditure	-59792000	-47206000	-26.66
depreciation and amortization	43402000	42274000	2.67
deferred income tax	-3766000	-26946000	86.02
stock based compensation	24109000	29946000	-19.49
accounts payables	4047000	3338000	21.24
inventory	7425000	-49060000	115.13
acquisitions net	0	4709000	-100.00
investments in property plant and equipment	-59792000	-47206000	-26.66
net cash used for investing activites	-83293000	-280743000	70.33
debt repayment	0	0	NaN
common stock issued	2012000	1570000	28.15
common stock repurchased	0	0	NaN
dividends paid	-66735000	-56996000	-17.09
net cash used provided by financing activities	-72929000	-64635000	-12.83
cash at end of period	91985000	93430000	-1.55
accounts receivables	-47186000	14975000	-415.10
cash at beginning of period	93430000	311993000	-70.05

Overall Score of Annual Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -1 million in 2023 from -219 million in 2022 representing a change of 99.34%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 155 million in 2023 from 127 million in 2022 representing a change of 22.05%. This indicates that the company generated more cash from its core business operations.

  Capital Expenditure: Capital Expenditure decreased to -60 million in 2023 from -47 million in 2022 representing a change of -26.66%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 24 million in 2023 from 30 million in 2022 representing a change of -19.49%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -47 million in 2023 from 15 million in 2022 representing a change of -415.1%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Free Cash Flow: Free Cash Flow decreased to 28 million in 2023 from 80 million in 2022 representing a change of -64.3%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to -4 million in 2023 from -27 million in 2022 representing a change of 86.02%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 4 million in 2023 from 3 million in 2022 representing a change of 21.24%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -67 million in 2023 from -57 million in 2022 representing a change of -17.09%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001005284
operating cash flow	79858000	67013000	19.17
free cash flow	66232000	57885000	14.42
capital expenditure	-13626000	-9128000	-49.28
depreciation and amortization	10947000	11049000	-0.92
deferred income tax	-5476000	-3466000	-57.99
stock based compensation	5289000	9349000	-43.43
accounts receivables	36693000	-4802000	864.12
accounts payables	-2962000	20344000	-114.56
inventory	-4115000	1062000	-487.48
acquisitions net	0	0	NaN
investments in property plant and equipment	-13626000	-9128000	-49.28
net cash used for investing activites	-73670000	-29288000	-151.54
debt repayment	0	0	NaN
common stock issued	589000	548000	7.48
common stock repurchased	0	0	NaN
dividends paid	-19152000	-19158000	0.03
net cash used provided by financing activities	-19485000	-18881000	-3.20
net change in cash	-13297000	18844000	-170.56
cash at end of period	79559000	92856000	-14.32
cash at beginning of period	92856000	74012000	25.46

Overall Score of Quarterly Cashflow Statement

0.75 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -13 million in 2024Q3 from 19 million in 2024Q2 representing a change of -170.56%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Accounts Receivables: Accounts Receivables increased to 37 in 2024Q3 from -5 million in 2024Q2 representing a change of 864.12%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 80 million in 2024Q3 from 67 million in 2024Q2 representing a change of 19.17%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 66 million in 2024Q3 from 58 million in 2024Q2 representing a change of 14.42%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -14 million in 2024Q3 from -9 million in 2024Q2 representing a change of -49.28%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 5 million in 2024Q3 from 9 million in 2024Q2 representing a change of -43.43%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 3 million in 2024Q3 from 20 million in 2024Q2 representing a change of -114.56%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid increased to -19 million in 2024Q3 from -19 million in 2024Q2 representing a change of 0.03%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	12.12	13.01	-6.85
net income per share	4.27	4.43	-3.70
operating cash flow per share	3.25	2.68	21.61
free cash flow per share	0.6	1.68	-64.43
cash per share	10.81	12.19	-11.33
book value per share	30.43	26.91	13.07
tangible book value per share	28.06	25.6	9.61
shareholders equity per share	30.43	26.91	13.07
interest debt per share	0.48	0.78	-38.20
market cap	9096262292.94	5120053630.08	77.66
enterprise value	9027132292.94	5055662630.08	78.55
pe ratio	44.81	24.37	83.83
price to sales ratio	15.78	8.3	90.05
pocfratio	58.77	40.37	45.56
pfcf ratio	320.04	64.32	397.62
pb ratio	6.29	4.01	56.56
ptb ratio	6.29	4.01	56.56
ev to sales	15.66	8.2	91.00
enterprise value over ebitda	34.64	16.34	111.99
ev to operating cash flow	58.32	39.87	46.30
ev to free cash flow	317.61	63.51	400.13
earnings yield	0.02	0.04	-45.60
free cash flow yield	0.0	0.02	-79.90
debt to equity	0.02	0.02	-30.64
debt to assets	0.01	0.02	-27.72
net debt to ebitda	-0.27	-0.21	-27.46
current ratio	7.72	6.63	16.45
interest coverage	0	34.2	-100.00
income quality	0.76	0.6	26.29
dividend yield	0.01	0.01	-34.09
payout ratio	0.33	0.27	21.15
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.23	0.19	19.23
intangibles to total assets	0.07	0.04	66.56
capex to operating cash flow	0.39	0.37	3.78
capex to revenue	0.1	0.08	35.49
capex to depreciation	1.38	1.12	23.37
stock based compensation to revenue	0.04	0.05	-13.88
graham number	54.06	51.81	4.35
roic	0.12	0.15	-22.51
return on tangible assets	0.13	0.14	-8.67
graham net net	10.2	10.16	0.42
working capital	798310000	763753000	4.52
tangible asset value	1334492000	1213205000	10.00
net current asset value	695397000	641999000	8.32
invested capital	1111104000	969362000	14.62
average receivables	116257000	100151500	16.08
average payables	10226000	12237000	-16.43
average inventory	179507500	158690000	13.12
days sales outstanding	88.55	54.85	61.44
days payables outstanding	29.48	27.17	8.51
days of inventory on hand	473.98	522.89	-9.35
receivables turnover	4.12	6.65	-38.06
payables turnover	12.38	13.44	-7.84
inventory turnover	0.77	0.7	10.32
roe	0.14	0.16	-14.83
capex per share	1.26	1.0	26.21

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 44.81 on 2023-12-31 from 24.37 on 2022-12-31, representing a change of 83.83%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.02 on 2023-12-31 from 0.02 on 2022-12-31, representing a change of -30.64%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio increased to 7.72 on 2023-12-31 from 6.63 on 2022-12-31, representing a change of 16.45%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
OLED
calendar year	2024	2024	NaN
revenue per share	3.4	3.33	1.99
net income per share	1.41	1.1	27.79
operating cash flow per share	1.68	1.41	19.19
free cash flow per share	1.39	1.22	14.44
cash per share	11.6	11.16	3.98
book value per share	33.38	32.11	3.94
tangible book value per share	31.29	29.93	4.55
shareholders equity per share	33.38	32.11	3.94
interest debt per share	0.42	0.52	-18.41
market cap	9979089728.6	9919372748.23	0.60
enterprise value	9919642728.6	9851171748.23	0.70
pe ratio	37.31	47.38	-21.26
price to sales ratio	61.74	62.58	-1.34
pocfratio	124.96	148.02	-15.58
pfcf ratio	150.67	171.36	-12.08
pb ratio	6.29	6.5	-3.20
ptb ratio	6.29	6.5	-3.20
ev to sales	61.37	62.15	-1.25
enterprise value over ebitda	127.25	174.55	-27.10
ev to operating cash flow	124.22	147.0	-15.50
ev to free cash flow	149.77	170.19	-12.00
earnings yield	0.01	0.01	27.00
free cash flow yield	0.01	0.01	13.74
debt to equity	0.01	0.02	-21.51
debt to assets	0.01	0.01	-19.97
net debt to ebitda	-0.76	-1.21	36.89
current ratio	7.18	6.31	13.75
interest coverage	0	0	NaN
income quality	1.19	1.28	-6.94
dividend yield	0.0	0.0	-0.63
payout ratio	0.29	0.37	-21.76
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.22	0.23	-3.89
intangibles to total assets	0.05	0.06	-6.20
capex to operating cash flow	0.17	0.14	25.27
capex to revenue	0.08	0.06	46.39
capex to depreciation	1.24	0.83	50.67
stock based compensation to revenue	0.03	0.06	-44.52
graham number	32.5	28.2	15.25
roic	0.03	0.03	16.93
return on tangible assets	0.04	0.03	24.87
graham net net	10.12	9.67	4.62
working capital	810681000	807482000	0.40
tangible asset value	1487664000	1423200000	4.53
net current asset value	717714000	709758000	1.12
invested capital	1123176000	1119685000	0.31
average receivables	106039500	134578500	-21.21
average payables	24167000	18238500	32.51
average inventory	173900500	172374000	0.89
days sales outstanding	48.83	70.63	-30.86
days payables outstanding	54.86	49.47	10.90
days of inventory on hand	390.85	359.67	8.67
receivables turnover	1.84	1.27	44.64
payables turnover	1.64	1.82	-9.83
inventory turnover	0.23	0.25	-7.98
roe	0.04	0.03	22.94
capex per share	0.29	0.19	49.30

• Negative

  ROE: Return on Equity (ROE) increased to 0.04 on 2024-09-30 Q3 from 0.03 on 2024-06-30 Q2, representing a change of 22.94%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 37.31 on 2024-09-30 Q3 from 47.38 on 2024-06-30 Q2, representing a change of -21.26%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 7.18 on 2024-09-30 Q3 from 6.31 on 2024-06-30 Q2, representing a change of 13.75%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.01 on 2024-09-30 Q3 from 0.02 on 2024-06-30 Q2, representing a change of -21.51%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 57.78 which is lower than current price 149.24, indicates the company may be overvalued.